Abingworth as of Dec. 31, 2017
Portfolio Holdings for Abingworth
Abingworth holds 17 positions in its portfolio as reported in the December 2017 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Crispr Therapeutics (CRSP) | 33.2 | $46M | 2.0M | 23.47 | |
| Sientra | 22.4 | $31M | 2.2M | 14.03 | |
| Paratek Pharmaceuticals | 13.5 | $19M | 1.0M | 17.90 | |
| Cymabay Therapeutics | 7.7 | $11M | 1.1M | 9.20 | |
| Obseva Sa | 3.1 | $4.3M | 440k | 9.75 | |
| Gtx Inc Del | 3.1 | $4.3M | 339k | 12.62 | |
| Proteon Therapeutics | 2.7 | $3.7M | 2.0M | 1.85 | |
| Chiasma | 2.5 | $3.4M | 2.1M | 1.65 | |
| Cascadian Therapeutics | 2.5 | $3.4M | 925k | 3.70 | |
| Cellectis S A (CLLS) | 2.1 | $2.9M | 100k | 29.15 | |
| Dermira | 1.4 | $1.9M | 70k | 27.81 | |
| Histogenics Corp Cmn | 1.3 | $1.8M | 889k | 2.03 | |
| Ultragenyx Pharmaceutical (RARE) | 1.3 | $1.8M | 38k | 46.38 | |
| Adaptimmune Therapeutics (ADAP) | 1.2 | $1.7M | 250k | 6.68 | |
| Immune Design | 1.0 | $1.4M | 352k | 3.90 | |
| Aurinia Pharmaceuticals (AUPH) | 0.8 | $1.1M | 252k | 4.53 | |
| Lombard Med (EVARF) | 0.3 | $382k | 3.5M | 0.11 |
